Gabapentin
Product Images NDC 76267-150

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 76267-150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allied Pharma Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

600mg (600mg)

Gabapentin Tablets, USP 600 mg label from Allied Pharma Inc. The label indicates the dosage strength, prescription-only status, and package count of 100 tablets. It includes storage instructions, a pharmacist note to dispense the medication guide, and manufacturing information from Par Formulations Pvt Ltd in India with distribution by Allied Pharma Inc in Fords, NJ.*

FDA Label Image

800mg (800mg)

Gabapentin Tablets, USP 800 mg labeling for a bottle of 100 tablets from Allied Pharma Inc. The label includes dosage information, storage instructions, and states the product is prescription only. Manufactured for Allied Pharma Inc with details on manufacturing and packaging provided.*

FDA Label Image

Figure1.jpg (Figure1)

A bar chart comparing the percentage of responders at endpoint in two studies. Study 1 shows results for placebo (PBO) at 12% and Gabapentin (GBP) 3600 at 29%. Study 2 presents PBO at 14%, GBP 1800 at 32%, and GBP 2400 at 34%. Statistical significance is indicated by p-values less than 0.01 and 0.001 for Gabapentin doses versus placebo.*

FDA Label Image

Figure2.jpg (Figure2)

A scatter plot chart showing percentage difference versus daily dose in milligrams, comparing three studies labeled Study a, Study b, and Study c. The vertical axis represents difference (%) ranging roughly from 2 to 22, and the horizontal axis shows daily dose from 600 mg to 1800 mg. Study a is marked with black squares, Study b with gray squares, and Study c with white squares.*

FDA Label Image

Graph.jpg (Graph)

A line chart comparing mean pain scores over 8 weeks during a 4-week dose titration and a 4-week fixed dose period for Gabapentin 3600 mg/day versus placebo. The vertical axis shows mean pain score, and the horizontal axis shows time in weeks.*

FDA Label Image

Graph1.jpg (Graph1)

A line graph depicting mean pain scores over a period of 7 weeks in a clinical study comparing placebo and Gabapentin at doses of 1800 mg/day and 2400 mg/day. The X-axis represents time from baseline through a 3-week dose titration period followed by a 4-week fixed dose period, while the Y-axis shows the mean pain score ranging from 0 to 10. Gabapentin groups show a marked reduction in pain scores compared to placebo over time.*

FDA Label Image

Structure.jpg (Structure)

Chemical structure of gabapentin showing a cyclohexane ring attached to an amino group (CH2NH2) and a carboxyl group (CH2CO2H). This molecular diagram represents the active ingredient gabapentin.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.